Related Experiment Video
Updated: Oct 20, 2025

09:38
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
643
Cancer therapy with isolated limb perfusion
Summary
High-dose chemotherapy via isolated limb perfusion offers an alternative to amputation for advanced extremity sarcomas and melanoma metastases. This limb-sparing approach aims for local control in challenging cases.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Locally advanced soft tissue sarcomas and extremity melanoma metastases often necessitate radical surgical interventions like amputation for local control.
- Amputation can lead to significant functional impairment and reduced quality of life for patients.
Purpose of the Study:
- To evaluate isolated limb perfusion with high-dose chemotherapy as a limb-sparing alternative to amputation.
- To assess the efficacy and feasibility of this approach for managing challenging extremity malignancies.
Main Methods:
- The study focuses on the application of isolated limb perfusion (ILP) using high-dose chemotherapy.
- This technique involves temporarily isolating the affected limb's blood supply to deliver concentrated chemotherapy directly to the tumor site.
Main Results:
- Isolated limb perfusion with high-dose chemotherapy demonstrates potential as an alternative to amputation.
- This method may achieve local control for patients with advanced soft tissue sarcomas and melanoma metastases in the extremities.
Conclusions:
- Isolated limb perfusion represents a viable limb-sparing strategy for select patients with advanced extremity cancers.
- Further research is warranted to fully establish its role and optimize treatment protocols.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Tumor Immunotherapy
746
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
746

